Whittier Trust’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$903K Buy
8,845
+435
+5% +$38.8K 0.01% 404
2026
Q1
$616K Sell
8,410
-79
-0.9% -$6.09K 0.01% 417
2025
Q4
$685K Sell
8,489
-1,696
-17% -$134K 0.01% 400
2025
Q3
$789K Sell
10,185
-1,717
-14% -$118K 0.01% 376
2025
Q2
$821K Sell
11,902
-1,089
-8% -$71.4K 0.01% 415
2025
Q1
$880K Sell
12,991
-4,352
-25% -$260K 0.01% 398
2024
Q4
$778K Sell
17,343
-13,047
-43% -$732K 0.01% 422
2024
Q3
$1.91M Sell
30,390
-11,124
-27% -$649K 0.03% 282
2024
Q2
$2.45M Sell
41,514
-112,304
-73% -$7.03M 0.03% 250
2024
Q1
$12.3M Buy
153,818
+1,451
+1% +$111K 0.18% 116
2023
Q4
$12M Sell
152,367
-1,569
-1% -$112K 0.2% 110
2023
Q3
$10.7M Buy
153,936
+718
+0.5% +$50.9K 0.19% 111
2023
Q2
$10.6M Sell
153,218
-6,694
-4% -$476K 0.18% 117
2023
Q1
$11.9M Buy
159,912
+4,520
+3% +$379K 0.22% 107
2022
Q4
$14.5M Sell
155,392
-388
-0.2% -$37.4K 0.28% 84
2022
Q3
$14.9M Buy
155,780
+10,110
+7% +$1M 0.31% 77
2022
Q2
$13.5M Buy
145,670
+2,107
+1% +$206K 0.27% 87
2022
Q1
$14.5M Buy
143,563
+269
+0.2% +$28.3K 0.25% 98
2021
Q4
$14.8M Buy
143,294
+929
+0.7% +$85.8K 0.24% 99
2021
Q3
$12.1M Buy
142,365
+3,317
+2% +$278K 0.22% 107
2021
Q2
$11.6M Buy
139,048
+2,909
+2% +$238K 0.21% 112
2021
Q1
$10.2M Buy
136,139
+9,117
+7% +$664K 0.2% 115
2020
Q4
$8.67M Buy
127,022
+4,028
+3% +$262K 0.19% 120
2020
Q3
$7.18M Sell
122,994
-1,978
-2% -$123K 0.17% 126
2020
Q2
$8.12M Sell
124,972
-2,473
-2% -$156K 0.23% 107
2020
Q1
$7.56M Sell
127,445
-3,699
-3% -$247K 0.25% 97
2019
Q4
$9.74M Buy
131,144
+1,447
+1% +$102K 0.26% 99
2019
Q3
$8.18M Sell
129,697
-3,089
-2% -$183K 0.23% 107
2019
Q2
$7.24M Sell
132,786
-12,619
-9% -$680K 0.21% 113
2019
Q1
$7.84M Sell
145,405
-17,085
-11% -$1.05M 0.24% 106
2018
Q4
$10.6M Buy
162,490
+2,573
+2% +$192K 0.37% 71
2018
Q3
$12.6M Buy
159,917
+3,053
+2% +$218K 0.39% 68
2018
Q2
$10.1M Sell
156,864
-207
-0.1% -$13.6K 0.33% 89
2018
Q1
$9.77M Buy
157,071
+8,397
+6% +$602K 0.33% 90
2017
Q4
$10.8M Sell
148,674
-24,188
-14% -$1.76M 0.38% 77
2017
Q3
$14.1M Buy
172,862
+7,216
+4% +$571K 0.51% 54
2017
Q2
$13.3M Buy
165,646
+3,178
+2% +$251K 0.52% 49
2017
Q1
$12.8M Buy
162,468
+4,821
+3% +$385K 0.51% 53
2016
Q4
$12.4M Sell
157,647
-430
-0.3% -$34.8K 0.53% 50
2016
Q3
$14.1M Buy
158,077
+2,975
+2% +$281K 0.61% 40
2016
Q2
$14.8M Buy
155,102
+2,893
+2% +$288K 0.65% 38
2016
Q1
$15.8M Buy
152,209
+7,096
+5% +$690K 0.7% 36
2015
Q4
$14.2M Buy
145,113
+12,539
+9% +$1.23M 0.64% 38
2015
Q3
$12.8M Buy
132,574
+3,270
+3% +$344K 0.62% 41
2015
Q2
$13.6M Buy
129,304
+7,766
+6% +$793K 0.6% 45
2015
Q1
$12.5M Buy
121,538
+4,398
+4% +$445K 0.57% 46
2014
Q4
$11.3M Buy
117,140
+163
+0.1% +$14.4K 0.54% 52
2014
Q3
$9.31M Buy
116,977
+438
+0.4% +$34.5K 0.45% 58
2014
Q2
$8.78M Buy
116,539
+654
+0.6% +$49.4K 0.43% 61
2014
Q1
$8.68M Buy
115,885
+1,816
+2% +$128K 0.44% 58
2013
Q4
$8.16M Buy
114,069
+20
+0% +$1.28K 0.42% 62
2013
Q3
$6.47M Sell
114,049
-2,404
-2% -$143K 0.35% 83
2013
Q2
$6.66M Buy
+116,453
New +$6.75M 0.37% 77

Other funds holding CVS

Whittier Trust's CVS Position: Q2 2026 in Review

Whittier Trust increased its CVS Health (CVS) stake by 5.2% in Q2 2026, buying an estimated $38.8K and bringing the position to 8,845 shares worth $903K. The position accounts for 0.01% of the portfolio, ranked #404.

Whittier Trust first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.8M in Q1 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Whittier Trust held 8,845 shares of CVS Health worth $903K as of Q2 2026.
  • Whittier Trust bought 435 CVS Health shares in Q2 2026, an estimated $38.8K.
  • CVS Health made up 0.01% of Whittier Trust's portfolio in Q2 2026, its #404 holding.
  • Whittier Trust first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Whittier Trust's CVS Health position peaked at $15.8M in Q1 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.